Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WILLIAM B WHITE

Allopathic & Osteopathic Physicians Internal Medicine Hypertension Specialist

NPI
1760489546
CMS profile
262107
Location
FARMINGTON, CT

General Payments · PY2018–2024

$1,912,735.20

  • Reported across 420 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$357,301.85

63 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $357,301.85 63

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Sumitomo Pharma America, Inc. $119,915.00 11
E.R. Squibb & Sons, L.L.C. $86,062.50 13
JAZZ PHARMACEUTICALS INC. $41,506.25 8
Alnylam Pharmaceuticals Inc. $26,850.10 4
Acerta Pharma LLC $21,450.00 5
BeiGene USA, Inc. $15,438.00 4
UCB SA $15,420.00 6
AstraZeneca UK Limited $12,175.00 6
Takeda Pharmaceuticals U.S.A., Inc. $10,985.00 2
Retrophin, Inc. $7,500.00 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $173,222.34 83
PY2019 $298,459.18 74
PY2020 $194,888.25 33
PY2021 $344,373.75 61
PY2022 $318,384.08 59
PY2023 $226,105.75 47
PY2024 $357,301.85 63

Payment records · PY2024 (63)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $6,697.60 01/11/2024 Consulting Fee Undisputed 01/23/2026 1125834627 CMS
Alnylam Pharmaceuticals Inc. $6,581.25 02/01/2024 Consulting Fee Undisputed 01/23/2026 1125834637 CMS
Alnylam Pharmaceuticals Inc. $6,697.50 02/15/2024 Consulting Fee Undisputed 01/23/2026 1125834653 CMS
Alnylam Pharmaceuticals Inc. $6,873.75 04/11/2024 Consulting Fee Undisputed 01/23/2026 1125834661 CMS
AstraZeneca Pharmaceuticals LP $2,325.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104211457 CMS
AstraZeneca Pharmaceuticals LP $5,250.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1104626460 CMS
AstraZeneca Pharmaceuticals LP $3,187.50 08/14/2024 Consulting Fee Undisputed 01/23/2026 1105595179 CMS
AstraZeneca Pharmaceuticals LP $6,750.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1104299742 CMS
AstraZeneca Pharmaceuticals LP $3,937.50 11/15/2024 Consulting Fee Undisputed 01/23/2026 1104683569 CMS
AstraZeneca UK Limited $1,050.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 1093896610 CMS
AstraZeneca UK Limited $2,275.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1094003886 CMS
AstraZeneca UK Limited $3,150.00 06/20/2024 Consulting Fee Undisputed 01/23/2026 1093955650 CMS
AstraZeneca UK Limited $2,450.00 06/20/2024 Consulting Fee Undisputed 01/23/2026 1093963838 CMS
AstraZeneca UK Limited $1,950.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 1093899663 CMS
AstraZeneca UK Limited $1,300.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 1094036817 CMS
BeiGene USA, Inc. $3,675.00 02/27/2024 Consulting Fee Undisputed 01/23/2026 1120851520 CMS
BeiGene USA, Inc. $2,313.00 06/11/2024 Consulting Fee Undisputed 01/23/2026 1120866670 CMS
BeiGene USA, Inc. $6,650.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1120866672 CMS
BeiGene USA, Inc. $2,800.00 12/24/2024 Consulting Fee Undisputed 01/23/2026 1120866674 CMS
E.R. Squibb & Sons, L.L.C. $3,375.00 01/30/2024 Consulting Fee Undisputed 01/23/2026 1101527616 CMS
E.R. Squibb & Sons, L.L.C. $5,062.50 02/05/2024 Consulting Fee Undisputed 01/23/2026 1101527620 CMS
E.R. Squibb & Sons, L.L.C. $9,787.50 03/29/2024 Consulting Fee Undisputed 01/23/2026 1101527636 CMS
E.R. Squibb & Sons, L.L.C. $6,412.50 05/13/2024 Consulting Fee Undisputed 01/23/2026 1101527649 CMS
E.R. Squibb & Sons, L.L.C. $6,075.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1101527653 CMS
E.R. Squibb & Sons, L.L.C. $6,075.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1101527671 CMS
E.R. Squibb & Sons, L.L.C. $6,750.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1101527688 CMS
E.R. Squibb & Sons, L.L.C. $8,437.50 09/16/2024 Consulting Fee Undisputed 01/23/2026 1101527700 CMS
E.R. Squibb & Sons, L.L.C. $10,293.75 10/02/2024 Consulting Fee Undisputed 01/23/2026 1101527725 CMS
E.R. Squibb & Sons, L.L.C. $10,125.00 10/29/2024 Consulting Fee Undisputed 01/23/2026 1101527736 CMS
E.R. Squibb & Sons, L.L.C. $2,700.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1101527740 CMS
E.R. Squibb & Sons, L.L.C. $8,268.75 11/12/2024 Consulting Fee Undisputed 01/23/2026 1101527744 CMS
E.R. Squibb & Sons, L.L.C. $2,700.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1101527755 CMS
JAZZ PHARMACEUTICALS INC. $3,081.25 03/01/2024 Consulting Fee Undisputed 01/23/2026 1150231099 CMS
JAZZ PHARMACEUTICALS INC. $5,075.00 03/24/2024 Consulting Fee Undisputed 01/23/2026 1150231089 CMS
JAZZ PHARMACEUTICALS INC. $10,512.50 04/19/2024 Consulting Fee Undisputed 01/23/2026 1150231085 CMS
JAZZ PHARMACEUTICALS INC. $7,250.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 1150231091 CMS
JAZZ PHARMACEUTICALS INC. $3,806.25 06/01/2024 Consulting Fee Undisputed 01/23/2026 1150231087 CMS
JAZZ PHARMACEUTICALS INC. $3,806.25 06/01/2024 Consulting Fee Undisputed 01/23/2026 1150231093 CMS
JAZZ PHARMACEUTICALS INC. $3,081.25 06/28/2024 Consulting Fee Undisputed 01/23/2026 1150231095 CMS
JAZZ PHARMACEUTICALS INC. $4,893.75 12/02/2024 Consulting Fee Undisputed 01/23/2026 1150231097 CMS
Sumitomo Pharma America, Inc. $8,937.50 01/04/2024 Consulting Fee Undisputed 01/23/2026 1148935082 CMS
Sumitomo Pharma America, Inc. $9,425.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1148935084 CMS
Sumitomo Pharma America, Inc. $7,952.50 02/22/2024 Consulting Fee Undisputed 01/23/2026 1148935086 CMS
Sumitomo Pharma America, Inc. $6,662.50 03/07/2024 Consulting Fee Undisputed 01/23/2026 1148935088 CMS
Sumitomo Pharma America, Inc. $12,675.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 1148935090 CMS
Sumitomo Pharma America, Inc. $3,412.50 06/06/2024 Consulting Fee Undisputed 01/23/2026 1148935092 CMS
Sumitomo Pharma America, Inc. $1,462.50 06/06/2024 Consulting Fee Undisputed 01/23/2026 1148935094 CMS
Sumitomo Pharma America, Inc. $13,000.00 07/25/2024 Consulting Fee Undisputed 01/23/2026 1148935096 CMS
Sumitomo Pharma America, Inc. $23,887.50 08/01/2024 Consulting Fee Undisputed 01/23/2026 1148935098 CMS
Sumitomo Pharma America, Inc. $19,662.50 09/12/2024 Consulting Fee Undisputed 01/23/2026 1148935100 CMS
Sumitomo Pharma America, Inc. $12,837.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 1148935102 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,647.50 01/19/2024 Consulting Fee Undisputed 01/23/2026 1144970197 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,337.50 04/24/2024 Consulting Fee Undisputed 01/23/2026 1144970199 CMS
Travere Therapeutics, Inc. $1,100.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1149919483 CMS
Travere Therapeutics, Inc. $1,100.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1149919487 CMS
Travere Therapeutics, Inc. $1,550.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1149919491 CMS
Travere Therapeutics, Inc. $3,750.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1149919495 CMS
UCB SA $1,680.00 03/28/2024 Consulting Fee Undisputed 01/23/2026 1113951003 CMS
UCB SA $4,920.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1113951011 CMS
UCB SA $720.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1113951001 CMS
UCB SA $2,550.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1113951007 CMS
UCB SA $2,250.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1113951005 CMS
UCB SA $3,300.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 1113951009 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.